Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2019 Filed Jun 11, 2019 22:53 UTC |
Cable Thomas J.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016490 · doc4.xml · derivative · entry 1 Cable Thomas J. · CIK 0001472158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 18:51 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Righ to Buy) · Derivative | 10,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-19-016488 · doc4.xml · derivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,996 Underlying: Common Stock · 10,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On June 7, 2019, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the issuer's common stock. The shares have not been sold and the reporting person does not expect to sell the shares for the foreseeable future. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 18:51 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 10,000 | $6.05 | $60,500.00 |
DisclosureSEC source: 0000899243-19-016488 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:59 UTC |
Shah RajivDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016501 · doc4.xml · derivative · entry 1 Shah Rajiv · CIK 0001642407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:57 UTC |
Hood Leroy E. MD PhDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016497 · doc4.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:56 UTC |
HANISH ARNOLD CDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016495 · doc4.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:54 UTC |
Demopulos Peter A MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016492 · doc4.xml · derivative · entry 1 Demopulos Peter A MD · CIK 0001472161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:52 UTC |
Aspiri RayDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016489 · doc4.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| February 09, 2019 Filed Feb 13, 2019 01:52 UTC |
Bumol Thomas F.Director
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0000899243-19-003363 · doc4.xml · derivative · entry 1 Bumol Thomas F. · CIK 0001767077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-02-08 F1 · derivative.exercise_date: This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 01:53 UTC |
Demopulos Gregory A MDDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 425,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0000899243-19-003364 · doc4.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,000 Underlying: Common Stock · 425,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 8, 2019. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:55 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0000899243-19-003367 · doc4.xml · derivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 8, 2019. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 01:54 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0000899243-19-003365 · doc4.xml · derivative · entry 1 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 8, 2019. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · derivative · entry 9 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,996 Underlying: Common Stock · 8,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On August 31, 2018, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock. The shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,529 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · derivative · entry 8 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,529 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 8,000 | $6.05 | $48,400.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 6 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
SaleCommon Stock | 5,337 | $25.93 | $138,376.13 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 5 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F3 · price: This transaction was executed in multiple trades at prices ranging from $25.76 to $26.18; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
SaleCommon Stock | 2,192 | $25.31 | $55,469.44 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 4 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,982 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.76 to $25.72; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 31, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 7,529 | $4.10 | $30,868.90 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · derivative · entry 7 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,529 Underlying: Common Stock · 35,000 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
SaleCommon Stock | 35,000 | $24.45 | $855,750.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:32 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 35,000 | $4.10 | $143,500.00 |
DisclosureSEC source: 0000899243-18-023667 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,723 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · derivative · entry 8 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,529 Underlying: Common Stock · 35,000 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
SaleCommon Stock | 5,723 | $21.73 | $124,356.78 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 5 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F3 · price: This transaction was executed in multiple trades at prices ranging from $21.48 to $21.90; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 5,723 | $4.10 | $23,464.30 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 4 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · derivative · entry 7 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,996 Underlying: Common Stock · 8,000 shares Expires 2020-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On July 26, 2018, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock. The shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · derivative · entry 6 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,252 Underlying: Common Stock · 35,000 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 8,000 | $6.05 | $48,400.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
SaleCommon Stock | 35,000 | $21.53 | $753,686.50 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.45 to $21.63; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 35,000 | $4.10 | $143,500.00 |
DisclosureSEC source: 0000899243-18-020780 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,277 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-18-019862 · doc4.xml · derivative · entry 3 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,252 Underlying: Common Stock · 4,277 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
SaleCommon Stock | 4,277 | $21.48 | $91,886.21 |
DisclosureSEC source: 0000899243-18-019862 · doc4.xml · nonDerivative · entry 2 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,645 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, and amended on May 17, 2018. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.46 to $21.49; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
Exercise / conversionCommon Stock | 4,277 | $4.10 | $17,535.70 |
DisclosureSEC source: 0000899243-18-019862 · doc4.xml · nonDerivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:35 UTC |
Cable Thomas J.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017007 · doc4.xml · derivative · entry 1 Cable Thomas J. · CIK 0001472158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:38 UTC |
Shah RajivDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017013 · doc4.xml · derivative · entry 1 Shah Rajiv · CIK 0001642407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:37 UTC |
HANISH ARNOLD CDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017011 · doc4.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:35 UTC |
Hood Leroy E. MD PhDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017010 · doc4.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:35 UTC |
Demopulos Peter A MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017008 · doc4.xml · derivative · entry 1 Demopulos Peter A MD · CIK 0001472161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:35 UTC |
Aspiri RayDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017006 · doc4.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| May 15, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · derivative · entry 8 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,188 Underlying: Common Stock · 5,000 shares Expires 2023-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total number of shares subject to this option vested on September 3, 2014, and the remaining shares subject to the option vested and became exercisable in equal monthly installments over the 36 months following the initial vesting date. F3 · derivative.exercise_date: On May 15, 2018, the reporting person paid the exercise price and exercised options to purchase 5,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options exercised in this transaction have the same vesting terms described in footnote 2. Read SEC document |
| May 15, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,812 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · derivative · entry 7 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,188 Underlying: Common Stock · 12,812 shares Expires 2023-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total number of shares subject to this option vested on September 3, 2014, and the remaining shares subject to the option vested and became exercisable in equal monthly installments over the 36 months following the initial vesting date. Read SEC document |
| May 15, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionCommon Stock | 5,000 | $9.37 | $46,850.00 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · nonDerivative · entry 5 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
SaleCommon Stock | 12,812 | $24.95 | $319,659.40 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · nonDerivative · entry 4 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2017, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 15, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionCommon Stock | 12,812 | $9.37 | $120,048.44 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · nonDerivative · entry 3 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,980 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · derivative · entry 6 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 10,980 shares Expires 2023-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total number of shares subject to this option vested on September 3, 2014, and the remaining shares subject to the option vested and became exercisable in equal monthly installments over the 36 months following the initial vesting date. Read SEC document |
| May 14, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
SaleCommon Stock | 10,980 | $22.45 | $246,501.00 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · nonDerivative · entry 2 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2017, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 14, 2018 Filed May 16, 2018 22:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionCommon Stock | 10,980 | $9.37 | $102,882.60 |
DisclosureSEC source: 0000899243-18-013086 · doc4.xml · nonDerivative · entry 1 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2018 Filed Apr 10, 2018 20:00 UTC |
Kelbon Marcia S.VP Patent and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0000899243-18-009872 · doc4.xml · derivative · entry 1 Kelbon Marcia S. · CIK 0001472163 · VP Patent and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2028-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2018. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| April 08, 2018 Filed Apr 11, 2018 00:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0000899243-18-009873 · doc4.xml · derivative · entry 1 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2028-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2018. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| April 08, 2018 Filed Apr 11, 2018 22:00 UTC |
Demopulos Gregory A MDDirector · Chairman, CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0000899243-18-010008 · doc4.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2028-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2018. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| January 04, 2018 Filed Jan 6, 2018 01:00 UTC |
JACOBSEN MICHAEL AVP Finance and CAO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000899243-18-000628 · doc4.xml · derivative · entry 5 JACOBSEN MICHAEL A · CIK 0001529087 · VP Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,980 Underlying: Common Stock · 1,000 shares Expires 2023-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On January 4, 2018, the reporting person paid the exercise price and exercised options to purchase 1,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options exercised in this transaction have the same vesting terms described in footnote 2. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.